Aviance Capital Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-989
Closed -$229K 335
2024
Q2
$229K Buy
989
+19
+2% +$4.41K 0.03% 293
2024
Q1
$209K Sell
970
-60
-6% -$12.9K 0.03% 295
2023
Q4
$267K Sell
1,030
-5
-0.5% -$1.29K 0.06% 212
2023
Q3
$266K Hold
1,035
0.06% 213
2023
Q2
$295K Sell
1,035
-100
-9% -$28.5K 0.06% 215
2023
Q1
$316K Hold
1,135
0.07% 215
2022
Q4
$314K Sell
1,135
-50
-4% -$13.8K 0.07% 215
2022
Q3
$316K Sell
1,185
-197
-14% -$52.5K 0.08% 203
2022
Q2
$282K Sell
1,382
-590
-30% -$120K 0.06% 224
2022
Q1
$415K Sell
1,972
-78
-4% -$16.4K 0.08% 196
2021
Q4
$492K Sell
2,050
-8,849
-81% -$2.12M 0.08% 189
2021
Q3
$3.08M Buy
10,899
+1,409
+15% +$399K 0.54% 45
2021
Q2
$3.29M Sell
9,490
-2,870
-23% -$994K 0.57% 42
2021
Q1
$3.46M Buy
12,360
+49
+0.4% +$13.7K 0.67% 41
2020
Q4
$3.01M Sell
12,311
-715
-5% -$175K 0.61% 41
2020
Q3
$3.7M Buy
13,026
+558
+4% +$158K 0.83% 28
2020
Q2
$3.34M Buy
12,468
+396
+3% +$106K 0.82% 26
2020
Q1
$3.82M Buy
12,072
+893
+8% +$283K 1.2% 14
2019
Q4
$3.32M Sell
11,179
-4
-0% -$1.19K 0.85% 21
2019
Q3
$2.6M Buy
11,183
+5,229
+88% +$1.22M 0.77% 29
2019
Q2
$1.39M Sell
5,954
-452
-7% -$106K 0.38% 79
2019
Q1
$1.51M Buy
6,406
+556
+10% +$131K 0.43% 55
2018
Q4
$1.76M Sell
5,850
-1,128
-16% -$339K 0.62% 38
2018
Q3
$2.47M Buy
6,978
+100
+1% +$35.3K 0.6% 32
2018
Q2
$2M Buy
6,878
+3,040
+79% +$882K 0.58% 39
2018
Q1
$1.05M Buy
3,838
+229
+6% +$62.7K 0.32% 85
2017
Q4
$1.15M Sell
3,609
-142
-4% -$45.2K 0.38% 72
2017
Q3
$1.18M Sell
3,751
-625
-14% -$196K 0.4% 68
2017
Q2
$1.19M Buy
4,376
+1,106
+34% +$300K 0.38% 75
2017
Q1
$894K Buy
3,270
+37
+1% +$10.1K 0.33% 95
2016
Q4
$917K Sell
3,233
-961
-23% -$273K 0.32% 89
2016
Q3
$1.31M Buy
4,194
+251
+6% +$78.6K 0.46% 60
2016
Q2
$953K Sell
3,943
-314
-7% -$75.9K 0.35% 78
2016
Q1
$1.11M Sell
4,257
-966
-18% -$251K 0.39% 69
2015
Q4
$1.6M Buy
+5,223
New +$1.6M 0.55% 48